Stanford begins clinical trials to expand Pfizer vaccine access to young children | April 23, 2021 | Almanac | Almanac Online |

Almanac

News - April 23, 2021

Stanford begins clinical trials to expand Pfizer vaccine access to young children

by Kevin Forestieri

Stanford Health Care has begun laying the clinical groundwork to expand COVID-19 vaccine eligibility to the country's youngest children, joining in a nationwide trial to see how safe and effective the Pfizer vaccine is for people ages 2 to 5.

This story contains 649 words.

Stories older than 90 days are available only to subscribing members. Please help sustain quality local journalism by becoming a subscribing member today.

If you are already a subscriber, please log in so you can continue to enjoy unlimited access to stories and archives. Subscriptions start at $5 per month and may be cancelled at any time.

Log in     Subscribe

Email Staff Writer Kevin Forestieri at [email protected]

Comments

Post a comment

Sorry, but further commenting on this topic has been closed.

Stay informed.

Get the day's top headlines from Almanac Online sent to your inbox in the Express newsletter.